Mediclinic International

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Monday, February 20, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Monday, February 13, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Monday, February 13, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Hospital M&A Activity Slowed in Q4:2022, According to Acquisition Data from LevinPro HC

Retrieved on: 
Thursday, January 12, 2023

NEW CANAAN, Conn., Jan. 12, 2023 /PRNewswire-PRWeb/ -- Headwinds and market challenges took a toll on Hospital M&A activity in the fourth quarter of 2022. According to new acquisition data captured in the LevinPro HC platform, there were 19 transactions announced in the Hospital sector in Q4:22, a 10% decline from activity in Q3:22 when 21 deals were announced. Fourth quarter activity was virtually level with Q4:21 transaction volume when 18 deals were announced.

Key Points: 
  • Hospital M&A activity slowed in Q4:2022, according to acquisition data from LevinPro HC.
  • NEW CANAAN, Conn., Jan. 12, 2023 /PRNewswire-PRWeb/ -- Headwinds and market challenges took a toll on Hospital M&A activity in the fourth quarter of 2022.
  • According to new acquisition data captured in the LevinPro HC platform, there were 19 transactions announced in the Hospital sector in Q4:22, a 10% decline from activity in Q3:22 when 21 deals were announced.
  • Fourth quarter activity was virtually level with Q4:21 transaction volume when 18 deals were announced.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Thursday, February 2, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Thursday, February 2, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Thursday, February 2, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Thursday, February 2, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Thursday, February 2, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Thursday, February 2, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.